BACKGROUND: The presence of viability in an infarct zone implies an intact microvasculature. We hypothesized that coronary flow reserve (CFR), which assesses the microcirculation, would correlate with the extent of viability in infarction zones. METHODS: CFR was measured after stenting in 17 patients with single vessel disease >48 hours from infarction. Viability was determined with use of single-photon emission computed tomography sestamibi imaging. RESULTS: Sestamibi uptake in the infarct zone correlated with CFR in the infarct artery (r = 0.62, P =.008) and sestamibi uptake in the infarct zone was greater in patients with normal CFR than in patients with abnormal CFR (61.9 +/- 9.1% vs 46.3 +/- 9.6%, P =.004). In addition, CFR was greater in patients with viability compared with patients without viability (2.4 +/- 1.3 vs 1.4 +/- 0.4, P =.015). CONCLUSIONS: CFR correlates with the extent of viability after infarction. Preserved CFR in an infarct-related artery implies preserved viability.
BACKGROUND: The presence of viability in an infarct zone implies an intact microvasculature. We hypothesized that coronary flow reserve (CFR), which assesses the microcirculation, would correlate with the extent of viability in infarction zones. METHODS: CFR was measured after stenting in 17 patients with single vessel disease >48 hours from infarction. Viability was determined with use of single-photon emission computed tomography sestamibi imaging. RESULTS:Sestamibi uptake in the infarct zone correlated with CFR in the infarct artery (r = 0.62, P =.008) and sestamibi uptake in the infarct zone was greater in patients with normal CFR than in patients with abnormal CFR (61.9 +/- 9.1% vs 46.3 +/- 9.6%, P =.004). In addition, CFR was greater in patients with viability compared with patients without viability (2.4 +/- 1.3 vs 1.4 +/- 0.4, P =.015). CONCLUSIONS: CFR correlates with the extent of viability after infarction. Preserved CFR in an infarct-related artery implies preserved viability.
Authors: Amanda J Leblanc; Jeremy S Touroo; James B Hoying; Stuart K Williams Journal: Am J Physiol Heart Circ Physiol Date: 2011-12-02 Impact factor: 4.733
Authors: V Schächinger; B Assmus; J Honold; R Lehmann; W-K Hofmann; H Martin; S Dimmeler; A M Zeiher Journal: Clin Res Cardiol Date: 2006-01 Impact factor: 5.460
Authors: R Montisci; L Chen; M Ruscazio; P Colonna; C Cadeddu; C Caiati; M Montisci; L Meloni; S Iliceto Journal: Heart Date: 2006-01-31 Impact factor: 5.994
Authors: E Alvarez; N D Dalton; Y Gu; D Smith; A Luong; M Hoshijima; K L Peterson; J Rychak Journal: Am J Physiol Heart Circ Physiol Date: 2017-11-10 Impact factor: 4.733
Authors: Amanda J Leblanc; Quang T Nguyen; Jeremy S Touroo; Allison L Aird; Raymond C Chang; Chin K Ng; James B Hoying; Stuart K Williams Journal: Stem Cells Transl Med Date: 2013-10-08 Impact factor: 6.940
Authors: Colin Berry; Jamie Layland; Arvind Sood; Nick P Curzen; Kanarath P Balachandran; Raj Das; Shahid Junejo; Robert A Henderson; Andrew H Briggs; Ian Ford; Keith G Oldroyd Journal: Am Heart J Date: 2013-08-27 Impact factor: 4.749